UL Solutions Inc. · NYSE:ULS
UL Solutions — Q3 2026 Earnings Presentation
24 slides from UL Solutions's earnings presentation, Nov 3, 2026
Slide 1: Earnings presentation
UL SOLUTIONS INC. • Q3 2026 Earnings presentation
Slide 2: Forward looking statements
Forward looking statements This presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation may be forward-looking statements. These include stat
Slide 3: Strong Q3 execution reinforces our foundation for durable profitable growth
Strong Q3 execution reinforces our foundation for durable profitable growth Adjusted EBITDA margin1 expansion fueled by revenue growth and ongoing productivity improvements 7.0% 28.6% $0.62 Organic2 revenue Adjusted Adjusted Diluted growth EBITDA margin1 Earnings Per Share1 5.1% +90 10.7% Overall re
Slide 4: Q3 Industrial and Consumer revenue growth more than offset R&C Software divestiture
Q3 Industrial and Consumer revenue growth more than offset R&C Software divestiture $ in millions $20 $3 $838 $(1) $823 $32 +7.0% $(14) +5.1% $783 • EHS software divestiture Q3 2025 Industrial Consumer R&C Q3 2026 FX Acquisition/ Q3 2026 Organic Organic Software Organic Divestiture Organic 4
Slide 5: Q3 Adjusted EBITDA margin increased 90 bps
Q3 Adjusted EBITDA margin 26.0% increased 90 bps $ in millions % Adjusted EBITDA margin $55 $247 $— $235 $217 $(25) $(12) 28.6% 22.8% 27.7% • EHS software ($10) divestiture • Transaction ($3) costs • Other $1 Q3 2025 Organic Organic Q3 2026 FX Acquisition/ Q3 2026 Revenue Expenses Organic Divestitur
Slide 6: YTD revenue grew across the refined portfolio
YTD revenue grew across the refined portfolio $ in millions $9 $2,410 $15 $50 $2,397 $87 +6.4% $(28) +5.9% $2,264 • EHS software divestiture Q3 2025 Industrial Consumer R&C Q3 2026 FX Acquisition/ Q3 2026 YTD Organic Organic Software YTD Organic Divestiture YTD Organic 6
Slide 7: YTD Adjusted EBITDA margin improved 180 bps
YTD Adjusted EBITDA margin 26.0% improved 180 bps $ in millions % Adjusted EBITDA margin $146 $680 $651 $(41) $(1) $575 $(28) 27.2% 22.8% 25.4% • EHS software ($19) divestiture • Transaction ($11) costs • Other $2 Q3 2025 YTD Organic Organic Q3 2026 YTD FX Acquisition/ Q3 2026 YTD Revenue Expenses O
Slide 8: Q3 Adjusted Diluted Earnings Per Share rose 10.7%
Q3 Adjusted Diluted Earnings Per Share rose 10.7% $0.27 $0.02 $0.62 $0.56 $(0.15) $(0.01) $(0.05) $(0.02) 14.5% 11.3% 2 Q3 2025 Organic Organic Interest Tax Acquisition/ Other Q3 2026 1 Revenue Expenses Divestiture 1. "Acquisition / Divestiture” includes, among other things, the change in transactio
Slide 9: Industrial: Energy and automation and materials drove growth
Industrial: Energy and automation and Revenue materials drove growth +8.2% $410 Q3 2026 results $379 • +8.2% Revenue growth +8.4% Organic Q3 2025 Q3 2026 – Continued momentum in ongoing certification services and certification testing – Industrial excluding Advisory1 grew ~9.0% Adjusted EBITDA and m
Slide 10: Consumer: Consumer technology and retail drove growth
Consumer: Revenue Consumer technology and retail drove growth +5.9% $360 $340 Q3 2026 results • +5.9% Revenue growth +5.9% Organic Q3 2025 Q3 2026 – Strength in non-certification testing and services and certification testing – Growth offset in part by ~150 bps reduction Adjusted EBITDA and margin %
Slide 11: Risk & Compliance Software: Steady organic growth
Risk & Compliance Software: Steady organic growth Revenue (17.2)% $64 $53 Q3 2026 results • (17.2)% Revenue decrease +4.7% Organic growth Q3 2025 Q3 2026 – EHS software sale closed April 1, 2026 – Sustained strong demand for supply chain insights Adjusted EBITDA and margin % • Adjusted EBITDA decrea
Slide 12: Cash flow grew alongside investment targeting growth opportunities
Cash flow grew alongside investment targeting growth LTM1 Cash Flow Operating Cash Flow Capital Expenditures opportunities $ in millions Free Cash Flow • Generated LTM1 Free Cash Flow of $738 $481M, an increase of $92M, 23.7% $586 • Benefited from strong business performance $481 $389 ($257) • Inves
Slide 13: Full-year outlook confirms growth and Adjusted EBITDA margin improvement
Full-year outlook confirms growth and Adjusted EBITDA margin improvement CAPITAL PORTFOLIO REVENUE PROFITABILITY TAX RATE EXPENDITURES OPTIMIZATION Constant currency Adjusted organic revenue EBITDA margin Effective Capital Continuing growth to improvement to tax rate of expenditures of to pursue app
Slide 14: E&E acquisition completed and integration underway
E&E acquisition completed and integration underway A highly complementary business that broadens our global TIC portfolio ~$200M 44 ~1,400 Annualized estimated 2026 revenue Global laboratories Employees October 1, 2026 Year-end 2027 Year-end 2028 Acquisition completed Back-office integration expecte
Slide 15: Appendix
Appendix
Slide 16: Components of revenue change
Components of revenue change Three Months Ended September 30, 2026 Acquisition / (in millions) Organic1 Divestiture2 FX3 Total Organic % change Total % change Revenue change Industrial $ 32 $ — $ (1) $ 31 8.4 % 8.2 % Consumer 20 — — 20 5.9 % 5.9 % Risk & Compliance Software 3 (14) — (11) 4.7 % (17.2
Slide 17: Adjusted EBITDA and Adjusted EBITDA margin (non-GAAP measures)
Adjusted EBITDA and Adjusted EBITDA margin (non-GAAP measures)1, 2 Three Months Ended Nine Months Ended September 30, September 30, (in millions, unless otherwise stated) 2026 2025 2026 2025 Net income $ 117 $ 106 $ 469 $ 274 Depreciation and amortization expense 49 46 142 137 Interest expense 6 10
Slide 18: Adjusted EBITDA and margin by segment (three months)
Adjusted EBITDA and Adjusted EBITDA margin (non-GAAP measures)1, 2 by segment Three Months Ended Three Months Ended Three Months Ended September 30, September 30, September 30, (in millions, unless otherwise stated) 2026 2025 (in millions, unless otherwise stated) 2026 2025 (in millions, unless othe
Slide 19: Adjusted EBITDA and margin by segment (nine months)
Adjusted EBITDA and Adjusted EBITDA margin (non-GAAP measures)1, 2 by segment Nine Months Ended Nine Months Ended Nine Months Ended September 30, September 30, September 30, (in millions, unless otherwise stated) 2026 2025 (in millions, unless otherwise stated) 2026 2025 (in millions, unless otherwi
Slide 20: Adjusted Net Income and Adjusted Net Income margin (non-GAAP measures)
Adjusted Net Income and Adjusted Net Income margin (non-GAAP measures)1, 2 Three Months Ended Nine Months Ended September 30, September 30, (in millions, unless otherwise stated) 2026 2025 2026 2025 Net income $ 117 $ 106 $ 469 $ 274 Gain on divestiture — — (191) — Other (income) expense, net (4) —
Slide 21: Adjusted Diluted Earnings Per Share (non-GAAP measure)
Adjusted Diluted Earnings Per Share (non-GAAP measure)1 Three Months Ended Nine Months Ended September 30, September 30, 2026 2025 2026 2025 Diluted earnings per share $ 0.53 $ 0.49 $ 2.19 $ 1.27 Gain on divestiture — — (0.94) — Other (income) expense, net (0.02) — (0.02) 0.03 Stock-based compensati
Slide 22: Free Cash Flow and Free Cash Flow margin (non-GAAP measures)
Free Cash Flow and Free Cash Flow margin (non-GAAP measures)1, 2 Nine Months Ended LTM3 September 30, September 30, (in millions, unless otherwise stated) 2026 2025 2026 2025 Net cash provided by operating activities $ 594 $ 456 $ 738 $ 586 Capital expenditures (199) (139) (257) (197) Free Cash Flow
Slide 23: Acquisition and Divestiture Transaction Costs
Acquisition and Divestiture Transaction Costs1 Change YoY on % (in millions, unless otherwise stated) 2026 % of revenue 2025 % of revenue of revenue Q1 $ 8 1.1 % $ 1 0.1 % 1.0 % Q2 5 0.6 % 4 0.5 % 0.1 % Q3 6 0.7 % 3 0.4 % 0.3 % Q4 Estimate (2026) / Actual (2025) 18 - 21 ~2.3 % 2 0.3 % ~2.0 % Full Ye
Slide 24: G@) Solutions
G@) Solutions